Tavis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 14,714 | 57,443 | 97,427 | 144,386 | 150,359 | 214,362 | 275,363 | 388,073 |
| Profit before tax | -834 | 9,188 | 8,594 | - | - | - | - | - |
| Net profit | -834 | 8,844 | 8,140 | 18,859 | 3,144 | 30,244 | 30,858 | 38,236 |
| Equity | 937 | 9,780 | 17,920 | 35,924 | 39,068 | 69,312 | 100,170 | 118,335 |
| Liabilities | 9,939 | 18,486 | 0 | 45,563 | 50,074 | 37,012 | 37,318 | 82,700 |
| Non-current assets | 1,454 | 4,265 | 3,085 | 3,598 | 19,060 | 20,636 | 33,901 | 31,215 |
| Current assets | 9,422 | 24,001 | 90,028 | 77,766 | 69,565 | 85,310 | 103,112 | 169,357 |
| Total assets | 10,876 | 28,266 | 93,113 | 81,364 | 88,625 | 105,946 | 137,013 | 200,572 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 47,579 | 62,438 | 94,951 |
| Social insurance contributions | - | - | - | - | - | 2,843 | 16,670 | 30,784 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +765.0% | +290.4% | +69.6% | +48.2% | +4.1% | +42.6% | +28.5% | +40.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -7.7% | 31.3% | 8.7% | 23.2% | 3.5% | 28.5% | 22.5% | 19.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -89.0% | 90.4% | 45.4% | 52.5% | 8.0% | 43.6% | 30.8% | 32.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -5.7% | 15.4% | 8.4% | 13.1% | 2.1% | 14.1% | 11.2% | 9.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -5.7% | 16.0% | 8.8% | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 10.6 | 1.9 | - | 1.3 | 1.3 | 0.5 | 0.4 | 0.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 11,036 | 25,530 | 33,403 | 54,144 | 41,961 | 67,693 | 57,971 | 65,589 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Tavis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-02-19 | 2024-02-19 | 39.21 |
| 2023-11-16 | 2023-11-16 | 756.48 |
Tavis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-19 | 2026-08-20 | 2.78 |
| 2026-08-14 | 2026-08-18 | 2.56 |
| 2026-08-12 | 2026-08-13 | 90.78 |
| 2026-07-30 | 2026-08-11 | 2.56 |
| 2026-06-28 | 2026-07-07 | 2.56 |
| 2026-04-08 | 2026-04-10 | 6.76 |
| 2026-03-08 | 2026-03-11 | 6.76 |
| 2025-04-02 | 2025-05-28 | 1.12 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Tavis, UAB (code 304548844) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €388.1K and net profit of €38.2K, with a profit margin of 9.9%. Revenue increased by 40.9% year on year and by 81.0% over two years, showing steady expansion from €214.4K in 2023 to €275.4K in 2024 and then to €388.1K in 2025. Net profit also improved gradually, from €30.2K in 2023 to €30.9K in 2024 and €38.2K in 2025. At year-end 2025, total assets stood at €200.6K, supported by equity of €118.3K and liabilities of €82.7K. The equity ratio was 59.0% and debt-to-equity was 0.70, indicating a solid capital structure. Return on equity was 32.3%, return on assets 19.1%, and asset turnover 1.93x. Revenue per employee was €77.6K, with profit per employee of €7.6K.